GlassScriptPhysician profile
Timothy J Rost
NPI 1275539439
$10,602.34
in general payments reported to CMS, 2019-2025
26 companies · $4,838 in 2025
The $4,838 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $257 · 2021: $362 · 2022: $55.45 · 2023: $41.20 · 2024: $4,855 · 2025: $4,838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,600 · Food and Beverage: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,600.00 |
| Food and Beverage | $134.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $9,600.00 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $187.94 | 2019-2022 | |
| Exeltis, USA INC. | $95.44 | 2019-2021 | |
| Therapeuticsmd, INC. | $60.94 | 2020-2021 | |
| Astellas Pharma US INC | $57.92 | 2023-2025 | Veozah |
| Merck Sharp & Dohme LLC | $57.53 | 2020-2021 | |
| Agile Therapeutics, INC. | $56.35 | 2021 | |
| Myovant Sciences INC. | $46.66 | 2021 | |
| Avion Pharmaceuticals | $46.14 | 2019-2021 | |
| Duchesnay USA Incorporated | $42.09 | 2019 | |
| Amag Pharmaceuticals, INC. | $38.35 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $37.65 | 2020-2023 | Exparel |
| Ethicon US, LLC | $37.40 | 2022 | |
| Hologic Sales and Service, LLC | $28.43 | 2019 | |
| Biogen, INC. | $22.98 | 2024 | Zurzuvae |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $21.98 | 2020 | |
| Pfizer INC. | $20.80 | 2021 | |
| Organon LLC | $20.51 | 2024 | |
| Millicent US INC | $19.79 | 2020 | |
| Becton, Dickinson and Company | $19.70 | 2021 | |
| Evofem Biosciences, INC. | $17.74 | 2021 | |
| Aspira Women'S Health INC | $15.47 | 2020 | |
| Mallinckrodt Enterprises LLC | $13.81 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.66 | 2021 | |
| Channel Medsystems, INC. | $11.99 | 2024 | |
| Allergan, INC. | $11.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Rost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.